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Recent studies indicated that the Zika virus genome could be detected in the amniotic
fluid and the fetal brain, which confirms that the virus can cross the placental barrier.
Secretory autophagy or exosome pathways may participate in this virus transfer.
Autophagy modulators regulate autophagosome formation or membrane fusion with
lysosomal vesicles and therefore inhibit viral nucleocapsid releasing or virus transfer
to the fetus hypothetically. However, some autophagy modulators may enhance virus
replication. Autophagy inhibitors may arrest placental development; while exaggeration
of autophagy in human placenta may be associated with the fetal growth restriction.
Therefore, autophagy modulators should be used carefully due to their complex clinical
effects. Alternatively, exosome-specific inhibitors might be also considered, although
their safety of both maternal and fetal conditions must be carefully assessed before any
advancement to human clinical trials.
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INTRODUCTION
A widespread epidemic of Zika virus (an emerging mosquito-borne flavivirus) infections was
found in Central and South America recently. The main concern is the significant increasing
of microcephaly in the fetus born to the mother of Zika virus infection (Faria et al., 2016).
Placenta may play an important role in the virus transfer. One possibility is that the Zika virus
can penetrate through the placental barrier. Alternatively, the infection to the placenta might
induce some immune responses and cause brain defects indirectly (Adibi et al., 2016a). A recent
study indicated that the viral genome could be detected in the amniotic fluid, which confirms
that the virus could penetration through the placental barrier (Calvet et al., 2016). The complete
genome of Zika virus can be also recovered from the fetal brain, which confirms the tropism
of Zika virus for neural tissues (Mlakar et al., 2016). Direct evidences of fluorescence in situ
hybridization (FISH) confirmed the presence of Zika virus RNA inmutiple mouse trophoblast cells,
such as glycogen trophoblasts, mononuclear trophoblasts, spongio-trophoblasts, and syncytio-
trophoblasts. Transmission electron microscopy of the mouse placenta found many 50-nm bodies
in the endoplasmic reticulum of trophoblast cells (Miner et al., 2016). Indirect immunoblotting
with the serum obtained from the infected mother found fluorescence signals in the destroyed
neuron cells. And negative staining of the infected fetal brain tissue showed 42–54 nm spherical
virus particles (Mlakar et al., 2016). Therefore the hypothesis that the virus could penetration
through the placental barrier has been confirmed.
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SECRETORY AUTOPHAGY MAY MEDIATE
ZIKA VIRUS TRANSFER
However, we still do not know by what exact mechanism
Zika virus transfers through the trophoblast cell. Like dengue
virus, Zika virus may be packaged as a cargo for the placental
exosome pathway at the trophoblast endoplasmic reticulum,
which is closely associated with the “secretory autophagy” process
(Chahar et al., 2015; Carneiro and Travassos, 2016). Autophagy
usually has a protective role by removing damaged organelles
and protein aggregates and maintaining cellular homeostasis
(Ponpuak et al., 2015). Contrasting to the degradative autophagy,
there is also a non-degradative autophagic machinery, termed
secretory autophagy (Ponpuak et al., 2015). Some proteins lack
the N-terminal leader peptides, and therefore cannot enter the
common endoplasmic-reticulum-to-Golgi-apparatus secretory
pathway. And these proteins (such as viral capsid polypeptides)
may be exported through the secretory autophagy pathway
unconventionally (Ponpuak et al., 2015). Different from the
degradative autophagy (fusion with the lysosome), the secretory
autophagy pathway may cause expulsion or secretion of the viral
particle other than its degradation (Figure 1). Zika virus infection
is associated with the observation of a lot of double membrane
intracytoplasmic vacuoles (namely the autophagosome). While
the co-detection of the virus envelope peptides and the autophagy
marker protein LC3 (cytosolic microtubule-associated light chain
3) has been reported (Hamel et al., 2015). Therefore, secretory
autophagy (or exosome) may facilitate Zika virus transfer across
the placental barrier, and regulations to the equilibrium between
degradative autophagy and secretory autophagy may influence
the incidence of microcephaly.
AUTOPHAGY INHIBITORS AND THE
CLINICAL EFFECTS
For some flaviviruses, upon binding to the receptor, the virus
enters the early endosome via the clathrin-mediated endocytic
process (Nour et al., 2013; Carneiro and Travassos, 2016). About
5min later, the virus particle fuses with the endosomal carrier
vesicle (ECV) membrane predominantly (Figure 1). However
for several minutes, viral nucleocapsids remain trapped in the
ECV lumen, until ECVs fuse back with the late endosome
limiting-membrane. These fusion events require microtubule
movement, some membrane fusion factors and the PI(3)P-
mediated signaling (Nour et al., 2013). PI(3)P kinase inhibitors,
3-methyladenine and wortmannin, inhibit both autophagosome
formation, and ECV formation (Nour et al., 2013). In the absence
of ECVs, the virus either fails to fuse fully with the early
endosome (only partial fusion to the proximal membrane) or it
fuses with some other endosomal vesicles but the nucleocapsid
still is trapped (Figure 1; Nour et al., 2013). Autophagosomes
were observed in human skin fibroblast cells infected with Zika
virus (Hamel et al., 2015). The specific autophagy inhibitor
3-methyladenine strongly reduces Zika viral copy numbers
in the infected fibroblast cells (Figure 1 and Table 1; Hamel
et al., 2015). However, neither 3-methyladenine nor wortmannin
is an FDA (the Food and Drug Administration) -approved
drug.
The cellular alkalizers also repress degradative autophagy
through neutralizing lysosomal acidic pH, which is necessary
for lysosomal hydrolases activations (Vakifahmetoglu-Norberg
et al., 2015). Chloroquine and its derivative hydroxychloroquine
are such alkalizers and are used clinically as anticancer drugs
or antimalarial candidate medicines (Vakifahmetoglu-Norberg
et al., 2015). Chloroquine had inhibitory effects on flavivirus
replication in vitro and significantly decreased Dengue virus type
2 replication in Aotus monkeys (Farias et al., 2015), but it did
not reduce the duration of viral infection in a human clinical trial
and showed several adverse effects, primarily vomiting (Tricou
et al., 2010). More importantly, chloroquine seems not to be
related with the equilibrium between degradative autophagy and
secretory autophagy (Figure 1 and Table 1).
In general, viruses customize autophagy protein for efficient
viral entry (Pirooz et al., 2014). However, some opposite
reports suggest that the involvement of autophagy in flavivirus
infection is controversial. ATG16L2 (Autophagy related 16-
like 2) was identified among the top 30 genes down-regulated
in human neural stem cells infected with Zika virus (Rolfe
et al., 2016). LC3 transcript was also down-regulated by Zika
virus infection in mice brain cells (Li et al., 2016). However,
West Nile virus infection did not induce LC3 lipidation in
multiple mammalian cell lines (Vandergaast and Fredericksen,
2012). And depletion of autophagy-related (ATG) protein ATG5
does not affect replication of West Nile virus (Vandergaast
and Fredericksen, 2012; Martín-Acebes et al., 2015). For mouse
embryonic fibroblast cells infected with Japanese encephalitis
virus, either depletion in ATG7 or deficiency in ATG5 would
result in higher viral replication levels (Sharma et al., 2014).
Autophagy may play a positive role in the early infection stages,
however it becomes dysfunctional when the misfolded proteins
accumulate at the late stages. Autophagy-deficient cells were
highly susceptible to virus-induced cell death (Sharma et al.,
2014). Therefore, the role of autophagy may be varied at different
infection stages. Autophagy inhibitors should be used carefully
because of their complex clinical effects.
The autophagy markers LC3-II and Beclin-1 are highly
expressed in villous cytotrophoblasts at the first trimester
and they are prevalently activated in trophoblast cells during
the whole gestation period (Chifenti et al., 2013). The
cytotrophoblast and the syncytiotrophoblast, which form the
placental barrier, function differently according to different
gestational ages. Autophagy plays an important role in the
placental development and pregnancy maintaining (Gong and
Kim, 2014). Therefore, autophagy inhibitors may produce
adverse effects to the fetus.
AUTOPHAGY STIMULATORS AND THE
CLINICAL EFFECTS
Metformin, a type 2 diabetes drug, induces autophagy by
activating AMPK (adenosine monophosphate-activated kinase)
pathways, may enhance antigen presentation and processing
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FIGURE 1 | Putative Zika virus entry pathway and the secretory autophagy/exosome pathway in the trophoblast cell. 3-methyladenine and wortmannin
inhibit both autophagosome formation and endosomal carrier vesicle formation (Nour et al., 2013). In the absence of these vesicles, Zika virus may either fail to fuse
completely with the early endosome membrane or it may fuse with as yet unidentified endosomal compartments in which the nucleocapsid remains trapped (Nour
et al., 2013). Chloroquine and its derivative hydroxychloroquine are lysosomal lumen alkalizers, which inhibit degradative autophagy by neutralizing the acidic pH in the
lumen of lysosomal vesicles (Vakifahmetoglu-Norberg et al., 2015). Metformin (Fedson, 2013) and Carbamazepine (Schiebler et al., 2015) induce autophagic killing of
pathogenic microbes (degradative autophagy). mTORC inhibitors Torin 1 and rapamycin stimulate autophagy, but inhibit exosome release evidently (Fader et al., 2008),
therefore limiting Zika virus transfer through the placental barrier. However, Torin 1 and rapamycin may enhance virus replication (Hamel et al., 2015). Alternatively,
exosome-specific inhibitors nSMase2, GW4869 and spiroepoxide (Li et al., 2013) may prevent the transfer, although their drug safeties need further studies.
and improve maintenance of memory CD8 cytotoxic T
lymphocytes after influenza virus infections (Fedson, 2013).
Carbamazepine, an anticonvulsant drug, was indicated to
trigger inositol-depletion dependent degradative autophagy of
intracellular Mycobacterium tuberculosis (a pathogenic bacteria)
in macrophages, which relieves pulmonary symptoms and
activate mouse’s immunity against the bacterium (Schiebler
et al., 2015). Statin (a lipid-lowering medicine) reduced the M.
tuberculosis proliferation in human and mouse macrophage cells
through promoting phagosome maturation (Parihar et al., 2014).
Membrane remodeling and viral replication usually induce
the endoplasmic-reticulum stresses that cause the unfolded-
protein responses (Blázquez et al., 2014). Concomitant with the
induction of the unfolded protein response, flavivirus infections
induced autophagy-related pathway activation has been also
described (Blázquez et al., 2014). For the instance of West
Nile virus, stimulation of autophagy via apro-autophagic peptide
(Tat-beclin 1-derived from a region of the autophagy protein
beclin 1) can protect neuronal cells from cell death caused by
the virus infection (Shoji-Kawata et al., 2013). Thus, drugs that
promote autophagy might have broad therapeutic applications
(Table 1; Zumla et al., 2016).
Among the common autophagy stimulators, only rapamycin
(a mTORC1 inhibitor) has been shown to inhibit exosome
release evidently (Fader et al., 2008). Given that exosome may
play a key role in Zika virus transfer, rapamycin might limit
Zika virus transfer through the placental barrier. However,
Torin 1 (another mTORC inhibitor) greatly enhances Zika virus
replication (Hamel et al., 2015). Thus, the rapamycin may not be
used as an efficient drug for the treatment of Zika virus infection.
Furthermore, misregulated autophagy may result in adverse
consequences to the fetus. For example, exaggeration of
autophagy in human placenta is associated with the fetal growth
restriction (Curtis et al., 2013). Therefore, autophagy stimulators
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TABLE 1 | List of autophagy and exosome modulators and the clinical effects to virus or bacterial infections.
Drug’s name Pathways involved in Clinical effects
3-Methyladenine
Wortmannin
PI(3)P kinase inhibitors; Autophagy inhibitors Reduce Zika viral copy numbers in the infected fibroblast cells
(Hamel et al., 2015)
Chloroquine
Hydroxychloroquine
Lysosomal lumen alkalizers; Autophagy inhibitors Decrease Dengue virus type 2 replication in Aotus monkeys (Farias
et al., 2015)
Metformin AMPK activator; Autophagy stimulator Enhances antigen processing and cytotoxic T lymphocytes after
influenza virus infections (Fedson, 2013)
Carbamazepine Induce inositol depletion -dependent autophagy Kill intracellular Mycobacterium tuberculosis; reduce tuberculosis
(Schiebler et al., 2015)
Statin Enhancing autophagy and phagosome maturation Reduces the Mycobacterium tuberculosis burden in human
macrophages (Parihar et al., 2014)
Apro-autophagic peptide Tat-beclin 1 Induce endoplasmic reticulum stress-associated autophagy Protect against neuronal cell death induced by the West Nile virus
infection (Shoji-Kawata et al., 2013)
Torin 1
Rapamycin
mTORC1 inhibitor; Autophagy stimulator May prevent Zika virus transfer through the placental barrier (Fader




Neutral sphingomyelinase inhibitor; Exosome inhibitor May prevent Zika virus transfer through the placental barrier (Li
et al., 2013)
should also be chosen carefully due to their complex clinical
effects.
EXOSOME-SPECIFIC INHIBITORS
Until now, the roles of autophagy in replication and secretion
have not been well-established as contradictory results have
been reported for different viruses. Hereby, some drugs
other than autophagy modulators should also be considered,
such as exosome-specific inhibitors nSMase2, GW4869, and
spiroepoxide (neutral sphingomyelinase inhibitors; Table 1;
Li et al., 2013). Sphingomyelinase and related ceramide
play important roles in embryo development and apoptosis
(de Castro e Paula and Hansen, 2008). However, alkaline
sphingomyelinase and neutral sphingomyelinase are functionally
similar. Neutral sphingomyelinase inhibitors might not cause
significantly adverse consequences to the fetus, because of the
complementation of alkaline sphingomyelinase. Nevertheless
during pregnancy, when the number of available drugs is
exceedingly limited and the bar for approval is extremely high, we
must be very cautious when testing any potential therapeutic that
could be used in human pregnancy. The safety of these exosome
inhibitors must be carefully assessed (especially in non-human
primates) before any advancement to human clinical trials.
Alternatively, new exosome inhibitors should be developed, such
as some natural compounds from soil actinomycetes (Dong et al.,
2005). Then their safety at both maternal and fetal conditions
requires further studies.
POTENTIAL COMBINATIONS WITH OTHER
DRUGS
We should keep in mind that the secretory autophagy (exosome)
may be only one of the complex mechanisms of Zika virus
penetration through the placental barrier. Zika virus infection
triggers apoptosis and vascular damages in the placenta, which
may increase the permeability of the placenta (Miner et al.,
2016). Therefore, Zika virus might be vertically transmitted
independent of the secretory autophagy (exosome) pathway. A
combination of antiviral agents and exosome inhibitors might
be required to achieve the desired effect. For example, both
type I interferons and type III interferons are induced by
Zika virus infections (Bayer et al., 2016; Quicke et al., 2016),
and interferon-λ restricts Zika virus replication in human
trophoblast cells (Bayer et al., 2016). Although, interferons and
associated cytokines may generate indirect teratogenic and/or
neurotoxic effects to the fetus (Adibi et al., 2016b; Mor, 2016),
interferon-α does not apparently increase the risk of miscarriage,
major malformation, preterm delivery, or stillbirth (Yazdani
Brojeni et al., 2012). Moreover, interferon-α may show some
protective effects against pregnancy loss in the case of essential
thrombocythemia (Yazdani Brojeni et al., 2012).
When Zika virus has penetrated the placenta, it may damage
the fetal brain directly or indirectly, because of its neurotropic
property (Mlakar et al., 2016). This assumption implies that the
virus exists in the fetal cerebral cortex at the early gestation
stages. However, at that time, the fetus is fairly-well shielded
frommaternal circulation.Maternal blood flows into the placenta
only after 10 weeks of gestation (Burton et al., 2001). Consistent
with these structure changes, a tissue-level analysis in a case
where the mother was infected at 7 weeks and miscarried at
12 weeks confirmed that the trophoblast was not infected by
Zika virus at that period (Noronha et al., 2016). When Zika
virus reaches trophoblast cells, non-neutralizing antibody and
the virus may form an immuno-complex (Toth et al., 1994).
And the exosome may be formed at that time, which may help
the immuno-complex to transfer through the placental barrier.
Nevertheless, the transfer is unlikely to be happened before 16
weeks of gestation (Saji et al., 1999; Fuchs and Ellinger, 2004).
Therefore, autophagy-related drugs or exosome inhibitors may
be not effective for the infected pregnant woman before 16 weeks.
Instead, for these patients, interferons may help their immune
system to clear the virus (Bayer et al., 2016; Quicke et al., 2016).
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Autophagy modulators or exosome inhibitors may be more
useful to the medium-late stage pregnant women.
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